Arkolith/Insider Trading/RLAY/Form 4

Bergstrom Donald A

President, R&DRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Jan 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$362K
Net Open-Market Flow
-$362K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2025Sell(S)31K$4.42$136K616K
Jan 29, 2025Sell(S)46K$4.55$211K647K
Jan 28, 2025Grant(A)176K—$0693K
Jan 28, 2025Sell(S)3K$4.63$15K517K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-011319) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML